Pharmabiz

Need to transition from awareness-driven reporting to performance-oriented PV framework: Dr Kalaiselvan

Need to transition from awareness-driven reporting to performance-oriented PV framework: Dr Kalaiselvan: Shardul Nautiyal, Mumbai Saturday, March 14, 2026, 08:00 Hrs [IST] There i ...
Pharmabiz

Centre amends MDR-2017 to include qualification for inspector & analyst for regulation of medical devices

Centre amends MDR-2017 to include qualification for inspector & analyst for regulation of medical devices: Gireesh Babu, New Delhi Saturday, March 14, 2026, 08:00 Hrs [IST] The Un ...
Pharmabiz

ESI pharmacist association urges 8th Pay Commission to rectify historical pay anomalies

ESI pharmacist association urges 8th Pay Commission to rectify historical pay anomalies: Peethaambaran Kunnathoor, Chennai Saturday, March 14, 2026, 08:00 Hrs [IST] The ESI Bellic ...
Pharmabiz

Heartfulness survey finds heavy AI users with high screen exposure reporting later bedtimes and rising daytime fatigue

Heartfulness survey finds heavy AI users with high screen exposure reporting later bedtimes and rising daytime fatigue: Our Bureau, Bengaluru Friday, March 13, 2026, 17:15 Hrs [IS ...
Pharmabiz

Amydis receives phase 2 NIH grant award of $2.5 million to advance a novel approach to detect biomarker TDP-43

Amydis receives phase 2 NIH grant award of $2.5 million to advance a novel approach to detect biomarker TDP-43: San Diego Friday, March 13, 2026, 18:00 Hrs [IST] Amydis Inc., a pr ...
Pharmabiz

US FDA launches new adverse event look-up tool

The US Food and Drug Administration (FDA) launched a new unified platform for analyzing adverse event reports. This platform — called the FDA Adverse Event Monitoring System (AEMS) — represents a ...
Pharmabiz

Shilpa Biologicals and mAbTree Biologics secure US FDA orphan drug designation for breakthrough biologics to treat rare blood cancers

Shilpa Biologicals and mAbTree Biologics secure US FDA orphan drug designation for breakthrough biologics to treat rare blood cancers: Our Bureau, Bengaluru Friday, March 13, 2026 ...
Pharmabiz

Citius Oncology reports positive results from phase 1 study of Lymphir in combo with pembrolizumab in relapsed or refractory gynaecologic cancers

Citius Oncology reports positive results from phase 1 study of Lymphir in combo with pembrolizumab in relapsed or refractory gynaecologic cancers: Cranford, New Jersey Friday, Mar ...
Pharmabiz

Breckenridge Pharma partners with Maiva Pharma to supply sterile injectables to hospitals and clinics in US

Breckenridge Pharma partners with Maiva Pharma to supply sterile injectables to hospitals and clinics in US: New Jersey Friday, March 13, 2026, 13:00 Hrs [IST] Breckenridge Pharma ...
Pharmabiz

WHO Foundation and Novo Nordisk collaborate to support childhood obesity prevention in India

WHO Foundation and Novo Nordisk collaborate to support childhood obesity prevention in India: Our Bureau, Mumbai Friday, March 13, 2026, 14:00 Hrs [IST] The WHO Foundation, an ind ...
Pharmabiz

‘Jamnagar Declaration’ proposes mercury banks & global safety standards for ayurvedic mercurial formulations

The Institute of Teaching and Research in Ayurveda (ITRA) recently concluded ‘Rasameemamsa-2026’, a landmark national conference at Jamnagar in Gujarat that culminated in the historic adoption of the ...
Pharmabiz

Former Odisha DC Dr Hrushikesh Mahapatra invited as resource person for national training programme

Former Odisha DC Dr Hrushikesh Mahapatra invited as resource person for national training programme: Our Bureau, Chennai Friday, March 13, 2026, 14:15 Hrs [IST] In a significant m ...